MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/pai.13432

Медицинская библиотека · Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2021

Use of premedication with intravenous immune globulin in Kawasaki disease: A retrospective review.

Liu Elaine, Gonzalez Jimmy, Siu Anita

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Kawasaki disease (KD) is a significant febrile illness in children and is the leading cause of acquired pediatric heart disease in developed countries. Its recommended treatment is high-dose intravenous immune globulin (IVIG) plus aspirin. However, IVIG-related adverse events are seen frequently in this population. Premedication is commonly used to reduce this risk, but evidence supporting this practice is conflicting. Ultimately, practices vary among institutions and no standard guidelines regarding IVIG premedication currently exist.

METHODS

Electronic medical records for pediatric patients presenting to an academic, tertiary care medical center diagnosed with KD and who received at least one dose of IVIG were reviewed for: patient demographics, treatment characteristics, premedication use, adverse events, and coronary abnormalities at discharge. Descriptive statistics were used to evaluate study findings.

RESULTS

Sixty-six patients receiving a total of 81 distinct IVIG administrations were evaluated. Most patients (64/66, 97%) were premedicated prior to infusion with 26% of patients (17/66) experiencing an IVIG-related adverse event, totaling 25 documented adverse events. The most common events included chills and vomiting. Overall, the average duration of hospitalization was 4.37 days. Despite appropriate medication management, five patients (7.6%) developed coronary abnormalities.

CONCLUSION

Practitioners demonstrated a widespread use of premedication for IVIG. However, 26% of patients still experienced an adverse event. While premedication was not shown to have an adverse impact on patient outcomes, it also did not demonstrate a notable reduction from a historic adverse event incidence.

Для цитирования: Liu Elaine, Gonzalez Jimmy, Siu Anita. Use of premedication with intravenous immune globulin in Kawasaki disease: A retrospective review.. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2021. DOI: 10.1111/pai.13432.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.